These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26599282)

  • 41. LncRNA
    Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
    Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.
    Yue D; Ren C; Li H; Liu X
    Medicine (Baltimore); 2024 Sep; 103(39):e39874. PubMed ID: 39331898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma.
    Wang J; Liu Y; Yang Y; Xu Z; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2016 Jul; 7(27):41986-41995. PubMed ID: 27259255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma.
    Can C; Acikalin MF; Ozen A; Dundar E
    Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
    Lee C; Park JW; Suh JH; Moon KC
    Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of SLC1a5 in lymph node metastases outperforms assessment in the primary as a negative prognosticator in non-small cell lung cancer.
    Csanadi A; Oser A; Aumann K; Gumpp V; Rawluk J; Nestle U; Kayser C; Wiesemann S; Werner M; Kayser G
    Pathology; 2018 Apr; 50(3):269-275. PubMed ID: 29455869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
    Choi JW; Lee JH; Park HS; Kim YS
    J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma.
    Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J
    Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.
    Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J
    Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma.
    Bai Q; Liu L; Xia Y; Wang J; Xi W; Qu Y; Xiong Y; Long Q; Xu J; Guo J
    Oncotarget; 2017 Jul; 8(27):44186-44194. PubMed ID: 28562332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S100A8 Expression May Have a Prognostic Value in CCRCC Reflecting TNM Staging and Fuhrman Nuclear Grade.
    An HJ; Koh HM; Song DH
    Anticancer Res; 2019 Sep; 39(9):4681-4685. PubMed ID: 31519567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
    Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
    Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
    Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
    Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
    Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.
    Hassanein M; Qian J; Hoeksema MD; Wang J; Jacobovitz M; Ji X; Harris FT; Harris BK; Boyd KL; Chen H; Eisenberg R; Massion PP
    Int J Cancer; 2015 Oct; 137(7):1587-97. PubMed ID: 25821004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TEK is a novel prognostic marker for clear cell renal cell carcinoma.
    Ha M; Son YR; Kim J; Park SM; Hong CM; Choi D; Kang W; Kim JH; Lee KJ; Park D; Han ME; Oh SO; Lee D; Kim YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1451-1458. PubMed ID: 30840266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.